Korean Stem Cell Drugs Push into Global Market – BusinessKorea
| BusinessKorea Korea-based biotechnology company Medipost announced on December 16 that it signed a license agreement with Indian pharmaceutical company Alkem Laboratories Ltd for its stem cell-based cartilage repair drug Cartistem. This is the first time for local … |
